Charles River Laboratories International Inc. CRL

NYS: CRL | ISIN: US1598641074   19/04/2024
226,78 USD (-0,34%)
(-0,34%)   19/04/2024
Grafiek Charles River Laboratories International Inc. Grafiek Charles River Laboratories International Inc.
donderdag 9 mei 2024, 13:00
Kwartaalcijfers (1ste kwartaal)

Charles River Laboratories International Inc. in het nieuws

29 februari 2024 · Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC® to Discovery Clients to Accelerate Their Journey to First-in-Human Use · Persbericht

16 juli 2023 · Kessler Topaz Meltzer & Check, LLP Notifies Charles River Laboratories International, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit · Persbericht

10 juli 2023 · CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit · Persbericht

10 juli 2023 · CRL INVESTOR NOTIFICATION: Kessler Topaz Meltzer & Check, LLP Announces Lead Plaintiff Deadline on July 18, 2023 in Securities Fraud Class Action Lawsuit Filed against Charles River Laboratories International, Inc. · Persbericht

8 juli 2023 · CHARLES RIVER LABORATORIES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Charles River Laboratories International, Inc. - CRL · Persbericht

2 juli 2023 · CRL Securities Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Charles River Laboratories International, Inc. (CRL) Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit · Persbericht

24 juni 2023 · CHARLES RIVER SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Options · Persbericht

24 juni 2023 · CHARLES RIVER LABORATORIES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Charles River Laboratories International, Inc. - CRL · Persbericht

23 juni 2023 · Kessler Topaz Meltzer & Check, LLP: Important Deadline Reminder for Charles River Laboratories International, Inc. Investors in Securities Fraud Class Action Lawsuit · Persbericht

23 juni 2023 · CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit · Persbericht

Profiel Charles River Laboratories International Inc.

charles river levert essentiële producten en diensten om farmaceutische en biotechnologische bedrijven, overheidsinstellingen en toonaangevende academische instellingen over de hele wereld te helpen hun onderzoek en inspanningen voor geneesmiddelenontwikkeling te versnellen. onze toegewijde medewerkers zijn erop gericht klanten precies te bieden wat ze nodig hebben om de ontdekking, ontwikkeling in een vroeg stadium en veilige productie van nieuwe therapieën te verbeteren en te versnellen voor de patiënten die ze nodig hebben. #drugdiscovery #biotech #biotechnologie #farmaceutica #cro

Commerciële diensten
Diverse commerciële diensten

Website: www.criver.com

Hoofdzetel: Wilmington, Massachusetts vlag Verenigde Staten

CEO: James Foster

Werknemers: 12.903

Aandelen Charles River Laboratories International Inc.

Beurswaarde: 11,68 miljard USD

Effecten: 51,51 miljoen

Winst per aandeel (12 maand):  PLUS

Koers-winstverhouding:  PLUS

Beta: 1,42

Mijn selecties